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This paper reports on the baseline prevalence and associated risk factor findings of a pilot,
longitudinal study exploring community-wide treatment of schistosomiasis and soil-transmit-
ted helminthiasis, using albendazole plus praziquantel in the Greater Accra region of
Ghana.
Method
From three communities, at least, 658 individuals were enrolled into the study via random
household selection. Prevalence and intensity of schistosomiasis and STH infection were
determined from stool and urine samples with a questionnaire being administered in order
to explore other morbidities and risk factors. Factor analysis of household demographic vari-
ables was undertaken to generate a socioeconomic score; this was then further categorised
into tertiles. Proportional-odds cumulative logit generalised estimating equation (GEE) mod-
els were used to investigate categorical ordinal intensity of infection associations with mor-
bidity. Separately, logistic GEE models were used to investigate risk factor associations with
infection prevalence.
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Results
Both Schistosoma haematobium and S. mansoni were prevalent in the three communities,
with the prevalence of S. haematobium ranging from 3.3% (24/679; 95% CI = 1.9–4.7) to
19% (114/632; 95% CI = 15.8–22.2) and S. mansoni ranging from 30% (202/679; 95% CI =
26.5–33.5) to 78.3% (409/536; 95% CI = 74.7–81.9). The total prevalence of STH across all
three sites was negligible at 1.3% (24/1847; 95% CI = 0.8–1.9) comprising mainly hookworm
(10/1847). Multivariable statistical models indicated males to be 2.3 (95% CI = 1.7–3.3)
times more likely to have a high intensity S. mansoni infection and 1.5 (95% CI = 1.1–2)
times more likely to have a high intensity of S. haematobium infection compared to females.
There was no significant difference in the likelihood of infection with S. mansoni between
adults and school age children (SAC), however S. haematobium infections were found to be
2.5 (95% CI = 1.8–3.5) times more likely to occur in school age children than in adults.
Multivariable statistical models (adjusted for age and sex) indicated an association
between schistosomiasis and a number of self-reported morbidity indicators (notably diar-
rhoea and blood in stool and urine). Low socio-economic status was also associated with
SCH infection (OR: 2; 95% CI = 1.3–3.2).
Conclusion
The communities targeted by this study showed a range of Schistosoma prevalence’s of
infection, from hypo-endemic through to meso-endemic and hyper-endemic. The preva-
lence of SCH across the different age groups in the study locations highlights the large num-
ber of individuals currently being left out of the standard morbidity control method of annual
treatment of the SAC.
Author summary
In this manuscript we detail the baseline results of a broader study investigating the feasi-
bility of expanding access of albendazole and praziquantel to additional at-risk groups in
three communities (Tomefa, Maheam and Torgahkope-Adakope) located around the
Weija reservoir in the Greater Accra district of Ghana. Our results show that intestinal
schistosomiasis was the most common form of disease across all three sites (44.2%) with
Tomefa possessing the highest prevalence at 78.3%. The prevalence of urinary schistoso-
miasis was found to be 11.9% with the highest prevalence found in Torgahkope-Adakope
(19%). STH was found to have a very low prevalence across the three communities with
only 1.3% of participants found to be positive. No significant difference in STH prevalence
was observed between males (0.92%; 95% CI = 0.4–1.81) and females (1.07%; 95% CI =
0.51–1.95). Statistical analysis revealed that males were more likely to be infected and to
have high intensity infections of both forms of schistosomiasis. Pre-school age children
(PSAC) were found to be less likely to be infected for either form of schistosomiasis in
communities with low to medium prevalence of disease, however in Tomefa, where preva-
lence of intestinal schistosomiasis is high, there was little difference in the prevalence of
disease between PSAC, school-age children (SAC) and adults. Our study shows that there
is a need to treat the wider community outside of the current morbidity control strategy
of mass-drug administration to SAC.
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Introduction
Schistosomiasis (SCH) and soil transmitted helminthiasis (STH) are two of the 18 listed
neglected tropical diseases (NTDs). Combined, they contribute the highest number of DALYs
of any NTD and approximately ~90% of all the cases attributed to the 18 NTDs [1]. Globally
four main species of STH are responsible for the majority of morbidity (Ascaris lumbricoides,
Trichuris trichiura, Necator americanus and Ancylostoma duodenale). Five species of Schisto-
soma are responsible for human schistosomiasis, globally, the three most common are Schisto-
soma mansoni (found in 55 countries), S. haematobium (found in 53 countries) and S.
japonicum (found in China, Indonesia and the Philippines). The global distribution of schisto-
somiasis is heavily skewed towards sub-Saharan Africa which contributes 93% of all schistoso-
miasis cases, currently estimated at 192 million cases [2].
The prevalence of STH in sub-Saharan Africa comprise 24–25% of all global infections of
the disease, with approximately 300 million cases of A. lumbricoides, 168 million cases of T. tri-
chiura and 200 million cases of hookworm [3].
The effects of these parasitic helminths on the host’s body are manifold including fatigue,
stunted growth and likely impaired cognitive function [4–6]. This is most acutely observed in
children where infection coincides with important developmental stages in the individual
where there is both physical and mental development [7]. There is growing evidence that both
STH and SCH contribute to higher levels of other infectious diseases such as tuberculosis [8],
HIV [9] and giardiasis [10]. The urinary form of schistosomiasis has also been associated with
bladder cancer [11]. Schistosoma haematobium infection can lead to male or female genital
schistosomiasis (MGS and FGS respectively) resulting in menorrhagia, dyspareunia, low fertil-
ity and increased risk of contracting sexually transmitted infections [12–14]. Neither form of
genital schistosomiasis is well understood but it is believed that FGS is one of the most wide-
spread, undiagnosed, gynaecological conditions in Africa with a conservative estimate predict-
ing that 19 million girls and women will develop FGS by 2023 [15].
The World Health Organization (WHO) recommends that the control efforts focus on
reducing morbidity for both SCH and STH by carrying out mass drug administration (MDA)
campaigns on school age children (SAC) and if possible on the pre-school age children
(PSAC) as well as girls and women of reproductive age [16–19]. The WHO’s push for SCH
control has been buoyed by the support of pharmaceutical companies who have pledged their
support for NTD control, with Merck having donated over 500 million praziquantel tablets to
date, since 2007 [20].
Both SCH and STH are prevalent in Ghana where the main control strategy follows WHO
recommendations for reducing childhood morbidity through annual MDA of praziquantel
(PZQ) and albendazole; Ghana has been implementing this strategy since 2005 for STH and
2008 for SCH. Whilst indicatively, expanding MDA to include PSAC and adults may improve
the effectiveness of SCH and STH control, as left untreated these two non-school cohorts act
as a reservoir for disease transmission. Without other interventions such as expanding access
to treatment to the whole community, implementation of WASH strategies, and/or snail-con-
trol, it will be unlikely to eliminate the transmission of either disease in hyper endemic areas,
through MDA alone [21–23]. Although the current evidence available for the impact of such
methods on STH is more limited than it is for SCH and this is reflected in the current draft for
2021–2030 roadmap for NTDs [24].
This argument for expanding the access to treatment, to the larger community, has been
supported by studies using mathematical models to explore the effectiveness of different treat-
ment strategies targeting STH [25–28]. These studies have suggested that it may be possible to
reach the transmission break-point through community wide MDA, however this would need
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to be at a high coverage (�75%) [27]. Some of these models have also shown that an annual
treatment with high community coverage has the potential to have a similar effect on child
morbidity as would biannual treatment of the child cohort. This benefit could also extend to
cost, in areas of high-transmission or where school-enrolment is low [28, 29]. Further support
for expanding treatment to additional community cohorts comes from the observed evidence
that different helminth parasites are found at differing prevalences, and intensities across the
various age groups [30]. For example A. lumbricoides is found in a higher abundance amongst
SAC whereas hookworm tends to be harboured, in greater number, by adults [26]. The same is
true of the two most important schistosome species, with S. haematobium found in higher
number and intensities in SAC and S. mansoni affecting both SAC and young adults in equal
number and intensity [31–33]. Although it is widely accepted that scale up should be imple-
mented where possible and it is likely going to be required to meet the 2020 goals, to date very
few national control programmes have implemented this strategy. This is likely due to the
donation of PZQ tablets being too few in number to treat whole communities in at risk areas
and the increased complexity of treating a more mobile adult population compared to SAC
[34].
Based on the World Health Organisations weekly epidemiological records from 2017 [35] it
can be estimated that 57.4 million children in Africa received treatment for schistosomiasis,
representing a coverage of 57.2%. A lower number of adults, 9.6 million, were reported to have
received treatment, equating to a coverage of 10.9%. The praziquantel coverage of PSAC is not
currently included in reports of coverage with regards to control of schistosomiasis. However,
it is reported in the coverage of STH treatment with >32 million treatments ascribed to PSAC,
resulting in a coverage of 32%. The treatment coverage for STH amongst the SAC population
in Africa is estimated to be 66.6% (117.5 million) in 2017. Of the adult population, only
women of reproductive age are considered in need of treatment for STH, currently there is no
data for Africa and only the global coverage for this cohort has been reported. Of the estimated
688 million women of reproductive age 127 million received treatment, representing a global
coverage of 18.5% [35]. It is likely that elimination of SCH and STH as a public health problem
would also require a holistic approach. The inclusion of snail control for SCH and the intro-
duction of improved water, sanitation and hygiene (WASH) practices; as health education and
behavioural change are key elements to controlling SCH and STH [36].
In Ghana a feasibility and acceptability study is being undertaken, aimed at exploring the
scaling up of PZQ and albendazole (ABZ) treatments to include pre-school age children
(PSAC), school aged children (SAC) and adults, including pregnant women (APW) [37].
Previous studies had highlighted specific risk factors associated with an increase in the like-
lihood that an individual would become infected. Notably age and sex are considered major
risk factors of schistosomiasis and hookworm infection in both males and individuals >10
years of age [38–40]. Socio economic status has also been implicated with the likelihood of
infection, although this was not always found to be the case [39, 40] with better access to clean
water, such as piped water, being a major contributor in cases of S. mansoni [41]. Specific
water-contact behaviours have also been identified to have a, significant, positive association
with heavy infection, the most important of these behaviours include swimming, bathing and
fishing [38, 41–45]. Morbidity indicators have also been identified that correlate with Schisto-
soma infection, although some of these are typically species specific, such as blood in stools
and blood in urine being associated with S. mansoni and S. haematobium respectively [46–53].
Similar risk factors and morbidity indicators have been identified for STH positive individuals,
these include the sex of individuals, lower socio-economic background, reduced access to
clean water, stunting, low weight and diarrhoea [40, 54–56].
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In this manuscript, the results of the baseline survey are analysed to quantify the prevalence
of SCH and STH, to determine the associations between WASH and demographic risk factors
with STH and SCH infection, and to investigate the associations between morbidity and the
intensities of STH and schistosomiasis infection, in the three study communities, as per the
study protocol published previously [37]. In brief this is the first component of the broader
study being conducted over the course of at least 18 months with four sampling rounds at
baseline, 6 months, 12 months and 18 months, to screen for SCH and STH.
Primary and secondary aims
The primary aim of this baseline survey is to report the prevalence and intensity of SCH and
STH in the three local communities selected.
Additional secondary aims include identifying associations with WASH indicators, demo-
graphic risk factors and infection of STH and SCH as well as, self-reported, morbidity indica-




Ethics for the study was obtained from the Liverpool School of Tropical Medicine (research
protocol 16–044) and the Council for Scientific and Industrial Research (CSIR), Ghana (RPN
003/CSIR-IRB/2016). All adults enrolled in the study provided informed, written, consent,
and written assent for their children.
Sample sites
Three sites were selected in the Greater Accra region based on national control survey data
using Kato-Katz to screen for SCH and STH infections. The sites selected had a minimum
SCH prevalence of�10% based on school surveys conducted in 2016. The following three
communities, Tomefa (longitude: -0.37688, latitude: 5.57309), Manheam (longitude: -0.39127,
latitude: 5.55229) and Torgahkope-Adakope (longitude: -0.38176, latitude: 5.6055) were
included in the study. All communities are situated around the Weija water reservoir (longi-
tude: -0.360714, latitude: 5.577372). All three sites closely border the reservoir and have low
levels of infrastructure with the percentage of households possessing their own latrines making
up only 27.3% (95% CI = 25.6–29.1) of households. The percentage of individuals reporting to
use a latrine or toilet, either personal or shared, was 57% (95% CI = 55–59), with 42.9% (95%
CI = 40.9–44.9) of participants defecating in either the bush, rivers or the reservoir.
Sample size calculation
The sample size calculation, has been previously described [37] but in brief due to the small
community sizes a hypergeometric formula was used assuming an estimated SCH prevalence
of 20%.
n ¼ Nz2rq=ðE2ðN   1Þ þ z2rqÞ
where: N = population size (1500 people); p = estimated prevalence (0.2); q = 1-p; E = accuracy
of estimation (0.03); z = 1.96 (confidence level 95%).
To take into account differences in relevant covariates, such as age and sex, a 40% buffer
was applied resulting in a baseline sample size of 658 people per community of 1,500 people.
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Enrolment and random household selection
Each community was sensitised to the project through meetings with village elders. Following
this sensitisation process every household in the community was visited and the number of
residents enumerated. These data were then used to estimate the number of households
needed to recruit the required number of participants based on the sample size calculation.
Households were then randomly selected to be approached for recruitment, using a post-
enumeration strategy of selecting odd-numbered houses. Where a household refused to partici-
pate or was absent the next enumerated house was selected, in accordance with the protocol
[37]. At each household the study was explained, allowing opportunity for questions and provi-
sion of written study pamphlets, after which individual written consent was obtained. An indi-
vidual and household questionnaire was conducted, and two specimen pots provided to each
enrolled participant with instructions for collection of faecal and urine specimens. The three
communities have estimated population sizes of ~911 for Torgahkope-Adakope, ~1,462 for
Tomefa and ~3,954 for Manheam. These figures were calculated based on the average house-
hold number for each community multiplied by the total number of enumerated households.
Parasitological analysis
The first bowel movement and urination of the day were requested from each enrolled partici-
pant for parasitological examination, each participant was requested to supply only a single
faecal and urine sample. Faecal and urine samples were examined by trained technicians using
two Kato-Katz slides per sample and the filtration of 10mL of urine for each participant. The
intensity of infection for the two schistosome species was calculated using the WHO guide (S.
mansoni: light-intensity 1–99 eggs, medium-intensity 100–399 eggs, heavy-intensity > = 400
eggs; S. haematobium: light-intensity 1–50 eggs, heavy-intensity >50 eggs). The urine samples
were also examined visually for haematuria and turbidity and with Hemastix Urine Test Strips
for the detection of microhaematuria. The interpretation of the turbid assessment of the urine
sample used an intensity scale based on visual guides to standardise the analysis (Fig 1).
A 25 μm pore Plastok (Birkenhead, UK) nylon filter, housed in a Swinnex filter holder, was
used to filter 10 mL of urine to screen for both S. haematobium and S. mansoni eggs. The Sterli-
tech (Kent, USA) Kato-Katz kit was used to screen the faecal samples for SCH and STH eggs, two
slides were made and examined for each faecal sample. Both the nylon filters and Kato-Katz slides
were examined as per WHO recommendations with the inclusion of a 10% quality control check.
Risk factor analysis
Two sets of questionnaires were administered to each household, the first was answered by the
head of the household and covered household-specific characteristics such as household
demographics and visual inspection of household water and sanitation facilities S1 Question-
naire). The second questionnaire was administered at an individual level and covered health
and hygiene behavioural patterns such as current health symptoms being experienced, history
of drug treatment, handwashing practices and participant defecation and urination practices
(S2 Questionnaire). For children aged less than 12 years a parent or guardian answered on
behalf of the child. All questionnaires used standardised questions used in previous studies
[54] and tested in-country with field-staff during training sessions.
Treatment and exclusion criteria
Treatment was offered to the entire community including those that were not enrolled in the
study, after all specimens had been received. The treatment consisted of praziquantel and
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albendazole tablets that were delivered by trained field staff from The Council for Scientific
and Industrial Research (CSIR) and Ghana Health Service Nurses. Praziquantel was adminis-
tered at 40 mg/kg and albendazole as a single 400mg dose, in accordance with WHO guide-
lines [18]. Treatment exclusion criteria included children who had already received annual
treatment at school, children under the age of one, seriously ill individuals and women in their
first trimester of pregnancy as determined by questionnaire. For PSAC between the ages of 1
and 4 where the child was unlikely to be able to take the drug in the conventional form it was
presented in a local meal called banku, made of a maize-flour paste.
Morbidity indicators
The inclusion of the individual and household surveys allowed this study to assess for morbid-
ity indicators in relation to WHO categorization intensities for S. mansoni and S. haemato-
bium infections from parasitological examination [17]. Participants from the three screened
communities were asked to self-report on a list of symptoms from the individual questionnaire
(S2 Questionnaire, question 8).
Statistical analysis
Descriptive statistics with 95% confidence intervals (CIs) were calculated for overall prevalence
and categories for intensities as per WHO guidelines for S. mansoni, S. haematobium and STH
infections. If overall prevalence was > 5%, stratified prevalences by gender, age-ranges and
community were also calculated. The arithmetic mean egg count was also calculated for inten-
sity of infection for each of the parasites, either as eggs per-gram (epg) or per 10mL.
Statistical models for prevalence of schistosomiasis in relation to WASH indicators.
To explore the relationship between the prevalence of schistosomiasis infection and WASH
indicators, two different logistic generalised estimating equation (GEE) models were separately
fitted for the categorical binary outcomes of S. mansoni and S. haematobium infections and
WASH indicators as explanatory variables using exchangeable covariance structure. Only
Fig 1. Visual guide used to standardise the assessment of urine turbidity.
https://doi.org/10.1371/journal.pntd.0007973.g001
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statistically significant covaries (i.e. by examining if p-values < = 0.0005 and their associated
95% CI) through a backward selection were retained in the final models and eventually pre-
sented. Sex and age were retained in all models. Due to the low observed STH prevalence sta-
tistical modelling was not conducted to quantify association between the prevalence of STH
infection and WASH indicators.
Multivariable Statistical models for WHO intensity categories of
schistosomiasis infections in relation to morbidity indicators
To identify baseline associations between intensities of infection and morbidity indicators, two
different proportional-odds cumulative logit generalized estimating equations (GEE) models
were fitted to the categorical ordinal outcomes of WHO intensity categories of S. mansoni and
S. haematobium infections and potential morbidity indicators as explanatory variables, using
independent covariance structure. Only statistically significant covariates (i.e. by examining if
p-values < = 0.005 and their associated 95% Confidence Intervals) through a backward selec-
tion were retained in the final models and eventually presented. A socioeconomic status (SES)
categorical variable (for further details of how this was derived, please see relevant section
below), was also tested and included as explanatory variable (or a covariate) in these models.
Sex and age were always retained in the presented models.
All the GEE models (proportional odds cumulative logit and logistic ones) as described
above, take into account the clustering of individuals by households. They were fitted by
employing PROC GENMOD in SAS v. 9.4 (SAS Institute Inc., Cary, NC, USA) producing esti-
mates of odds ratios (ORs) and their 95% CIs. Household-level variables were also tested and
included as explanatory variables (or covariates) in these models.
SES reduced measure
To derive an overall SES reduced measure, tested later as a covariate in the GEE proportional-
odds cumulative logit models, factor analysis for categorical data of the SES questions (Q52-
54, S2, Questionnaire) in the field surveys was first used. The derived factor score was then cat-
egorized based on cut-offs of tertiles of this variable into: ‘Low’, ‘Medium’ and ‘High’. Mplus
software [57] was used for the factor analysis of the relevant categorical data.
Results
Descriptive findings
A total of 2,623 people were enrolled into the study; 878 from Tomefa, 984 from Manheam
and 760 from Torgahkope-Adakope. Of those enrolled 1,834 individuals (69.9%; 95%
CI = 68.1–71.7) provided stool to be screened with Kato-Katz and 1,929 (73.5%; 95%
CI = 71.8–75.2) supplied urine to undergo urine filtration (Table 1).
Analysis of stool and urine samples across all three sites found the following prevalences for
SCH and STH: S. mansoni 44.2% (95% CI = 41.9–46.5), S. haematobium 11.9% (95%
CI = 10.4–13.3), hookworm 0.5% (95% CI = 0.2–0.9), Trichuris trichiura 0.4% (95% CI = 0–1.0),
Ascaris lumbricoides 0.1% (95% CI = 0–0.3), Strongyloides stercoralis 0.1% (95% CI = 0–0.3)
and Taenia s.p. 0.1% (95% CI = 0-<0.1). Whilst not listed as an STH the prevalence of Hyme-
nolepis spp was observed to be 0.4% (95% CI = 0.1–0.7). The prevalence of the different hel-
minth species across the three sampling locations is given in Table 2 and the distribution of
the two schistosome species at each site is given in Fig 2.
Exploring the observed prevalence of schistosomiasis across the different age groups
(PSAC, SAC and APW) within the three sampling sites, both the PSAC and APW show a high
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prevalence of disease. In Tomefa the prevalence of S. mansoni is significantly higher than the
other two sites as is the prevalence in the adult population (Table 3).
Comparison of the percentage prevalence across different age categories reveal that both
Schistosoma species have the highest prevalence in SAC but reduced in adulthood, however it
was only in S. haematobium that this difference was significant (Fig 3).
There was little difference in intensity of infection by age groups for S. mansoni. The distri-
bution of intensity for S. haematobium infection produced a different pattern, with little differ-
ence in prevalence of low intensity infections across the three age groups. However, for high-
intensity S. haematobium infections, these peaked amongst school age children and decreased
in the adult population (Fig 4).
Treatment coverage
Of the 2,623 individuals that were recruited to the study 1,840 (70.1%; 95% CI = 68.4–71.9)
received PZQ treatment, of those that did not receive treatment, 99 (3.8%; 95% CI = 3–4.5)
met the exclusion criteria [37], 354 (13.5%; 95% CI = 12.2–14.8) were absent, 170 refused
Table 1. Demographics of urine and faecal samples collected by the study per site.
Site Age Category Urine Provided Faeces Provided















Grand Total 1929 1834
https://doi.org/10.1371/journal.pntd.0007973.t001
Table 2. Prevalence of Schistosoma and STH positive samples across all three sites (CI).
Tomefa (n = 536) Manheam (n = 679) TorgahKope-Adakope (n = 632)
n = positives % (95% CI) n = positives % (95% CI) n = positives % (95% CI)
S. mansoni 409 78.3% (74.7–81.9) 202 30% (26.5–33.5) 196 31% (27.3–34.7)
S. haematobium 91 14.3% (11.5–17.1) 24 3.3% (1.9–4.7) 114 19% (15.8–22.2)
Hookworm 1 0.2% (0.0–1) 0 0 9 1.4% (0.7–2.7)
T. trichiura 0 0 3 0.4% (0.1–1.3) 0 0
Hymenolepis spp. 4 0.8% (0.2–1.9) 2 0.3% (0–1.1) 0 0
A. lumbricoides 2 0.4% (0–1.4) 0 0 0 0
S. stercoralis 0 0 0 0 2 0.3% (0–1.2)
Taenia spp. 0 0 1 0.1% (0–0.8) 0 0
https://doi.org/10.1371/journal.pntd.0007973.t002
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(6.5%; 95% CI = 5.5–7.4) and for 160 (6.1%; 95% CI = 5.2–7.0) their reasons for not receiving
treatment were unknown.
Similarly of the 2,623 participants enrolled in the study 1,849 (70.5%; 95% CI = 68.7–72.2)
received ALB, 40 (1.5%; 95% CI = 1.1–2) met the exclusion criteria, 354 (13.5%; 95%
CI = 12.2–14.8) were absent, 170 (6.5%; 95% CI = 5.5–7.4) refused and for 210 (8%; 95%
CI = 7–9) their reason for not receiving treatment is unknown. The treatment of both SAC
and adults in the community is given in Table 4, children treated at school, and therefore not
eligible to receive further MDA in this study, were included as “treated”.
Models for prevalence of schistosomiasis infection and related WASH
indicators
Table 5 contains results from multivariable GEE logistic models for prevalence of schistosomi-
asis infection related to WASH indicators. The first part of this table shows WASH associa-
tions with S. mansoni infection. Those urinating in school toilet were less likely to be infected
with S. mansoni than those who did not (OR: 0.5; 95% CI = 0.3–0.8; P = 0.007). Furthermore,
those who defecated on the ground were more likely to be infected with S. mansoni compared
to those who did not (OR: 1.3; 95% CI = 1–1.6; P = 0.025). Those living in households with
electricity were less likely to be infected with S. mansoni compared to those living in house-
holds which did not (OR: 0.2; 95% CI = 0.2–0.3, P =<0.001). Males were more likely to be
infected with S. mansoni than females (OR: 1.8; 95% CI: 1.4–2.2; P =<0.001). Finally, pre-
school children were less likely to be infected with S. mansoni than adults (OR: 0.3; 95% CI:
0.2–0.4; P = <0.001).
Those who urinated in school toilets and defecated in village toilets were less likely to be
infected with S. haematobium than those who indicated that they did not (OR: 0.2; 95% CI:
0.1–0.7; P = 0.009 and OR: 0.1 95% CI: <0.1–0.5, P =<0.001, respectively). Those who uri-
nated in ‘other’ sites and those who defecated in the neighbourhood toilet were more likely to
be infected with S. haematobium than those who indicated that they did not (OR: 2.1; 95%
CI = 1.1–4; P = 0.036 and OR: 1.9; 95% CI = 1.3–2.7; P =<0.001, respectively). Surprisingly,
those living in households with electricity were more likely to be infected with S. haematobium
(OR: 2.3; 95% CI = 1.7–3.2; P = 0.00). Males were more likely to be infected with S. haemato-
bium than females (OR: 1.7; 95% CI = 1.3–2.3; P = 0.001). Compared to adults pre-school chil-
dren were less likely (OR: 0.6; 95% CI = 0.3–1; P = 0.041) to be infected with S. haematobium
while school children were more likely (OR: 2.53; 95% CI = 1.8–3.5; P =<0.001).
Fig 2. Distribution of S. mansoni and S. haematobium positive and negative households in the following sampled communities (A) Tomefa, (B) Manheam, (C)
Torgahkope and (D) Adakope around the Weija reservoir, image created using ESRI ArcGIS [58].
https://doi.org/10.1371/journal.pntd.0007973.g002
Table 3. Prevalence of S. haematobium and S. mansoni infections in the three different age groups (PSAC, SAC and Adults) within each of the three sampling sites.
Age Group Tomefa Manheam TorgahKope-Adakope
n = positives
(Total)
% (95% CI) n = positives
(Total)
% (95% CI) n = positives
(Total)
% (95% CI)
S. mansoni Pre-School 54 (77) 70.1 (59.3–81) 9 (108) 7.9 (2.8–13.1) 13 (96) 13.7 (7.3–20.2)
School 153 (191) 80.1 (74.5–86.3) 89 (224) 39.9 (33.1–46.8) 86 (240) 35.9 (29.2–42.5)
Adult 200 (253) 79.1 (74.1–84.4) 107 (332) 32.1 (27–37.2) 100 (286) 34.8 (29.2–40.4)
S. haematobium Pre-School 4 (76) 5.2 (0.2–10.2) 0 (105) 0.0 (N/A) 11 (87) 13.2 (6.5–19.8)
School 59 (249) 23.8 (18.1–29.6) 14 (236) 5.8 (2.5–9.1) 63 (230) 27.6 (21.3–33.9)
Adult 32 (308) 10.3 (6.7–13.8) 10 (346) 2.9 (1–4.8) 41 (272) 15.1 (10.8–19.4)
https://doi.org/10.1371/journal.pntd.0007973.t003
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Models for schistosomiasis related morbidity indicators
Table 6 contains results from multivariable proportional-odds cumulative logit GEE models
for WHO intensity categories of S. mansoni and S. haematobium infections in relation to
potential morbidity indicators.
Fig 3. Prevalence of Schistosoma across different age groups for S. haematobium and S. mansoni showing the
percent positive per age group.
https://doi.org/10.1371/journal.pntd.0007973.g003
Fig 4. Infection intensity for (A) S. mansoni and (B) S. haematobium based on WHO egg count numbers across different age groups.
https://doi.org/10.1371/journal.pntd.0007973.g004
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Those replying ‘In last month’ for question ‘blood in stool’ were 1.6 times (95% CI = 1–2.6;
P = 0.05) more likely to have higher intensities of S. mansoni infection than those replying
‘Not in last month’ for this same question. Those replying ‘In last month’ for question ‘blood
in stool’ were 1.6 times (95% CI = 1–2.6; P = 0.05) more likely to have higher intensities of S.
mansoni infection than those replying ‘Not in last month’ for this same question.
Those reporting to currently have diarrhoea or who had diarrhoea in the last month were
also more likely to have a higher intensity infection of S. mansoni compared to those replying
‘Not in last month’ for this same question. Those replying ‘Currently’ and ‘In last month’ for
the question ‘blood in urine’ were more likely to have higher intensities of S. haematobium
infection compared to those who replied ‘Not in last month’ OR: 2.7 (95% CI = 1.6–4.6;
p<0.001) and OR: 2.2 (95% CI = 1.4–3.3; p = 0.001).
Males were 2.3 times (95% CI = 1.7–3.3; P =<0.000) more likely to have a high intensity
infection by S. mansoni and 1.5 times (95% CI = 1.1–2; P = 0.019) more likely to have a high
intensity S. haematobium compared to females. There was no significant difference in the asso-
ciation of age and high intensity infection status for S. mansoni between adults and PSAC (OR:
0.5; 95% CI = 0.1–2.2; P = 0.33) as well as adults and SAC (OR: 0.1; 95% CI = 0–1.1; P = 0.06).
For S. haematobium infections there was no significant difference between PSAC and adults;
however, between SAC and adults, SAC were 2.3 times (P =<0.00; 95% CI = 1.7–3.3) more
Table 4. Coverage of eligible PSAC, SAC and adults across all three sampling sites with regards to PZQ and ALB.
Drug Age Group Total Treated Coverage % (95% CI)
PZQ PSAC (0–4 yrs) 278 203 73 (67.4–78.1)
SAC (5–17 yrs) 519 420 80.9 (77.3–84.2)
Adults (18–75+ yrs) 1474 974 66.1 (63.6–68.5)
ALB PSAC (0–4 yrs) 403 312 77.4 (73–81.4)
SAC (5–17 yrs) 565 465 82.3 (78.9–85.4)
Adults (18–75+ yrs) 1284 901 70.2 (67.6–72.7)
https://doi.org/10.1371/journal.pntd.0007973.t004
Table 5. Odds Ratios (ORs) from two separate multivariable GEE logistic models for the outcomes of S. mansoni
(n = 1671) and S. haematobium (n = 1773) infections in relation to WASH indicators.
Comparisons between categories of covariates OR, (95% CI), p-value
S. mansoni Sex: Males vs Females 1.8 (1.4–2.2),<0.001
Age Category: Pre-School vs Adult 0.3 (0.2–0.4),<0.001
Age Category: School vs Adult 1.1 (0.9–1.4),0.308
Household electricity: Yes vs No 0.5 (0.4–0.6),<0.001
Urinate in school toilet:Yes vs No 0.5 (0.3–0.8),0.007
Defecate on the ground:Yes vs No 1.3 (1–1.6),0.025
Defecate in village toilet:Yes vs No 0.5 (0.3–0.7),<0.001
Comparisons between categories of covariates OR, (95% CI), p-value
S. haematobium Sex: Males vs Females 1.7 (1.5–2.3),0.001
Age Category: Pre-School vs Adult 0.6 (0.3–1),0.041
Age Category: School vs Adult 2.5 (1.8–3.5),<0.001
Household electricity: Yes vs No 2.3 (1.7–3.2),<0.001
Urinate in school toilet:Yes vs No 0.2 (0.1–0.7),0.009
Urinate in other site:Yes vs No 2.1 (1.1–4),0.036
Defecate in neighbor’s toilet:Yes vs No 1.9 (1.3–2.7),<0.001
Defecate in village toilet:Yes vs No 0.1 (<0.1–0.4),<0.001
https://doi.org/10.1371/journal.pntd.0007973.t005
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likely to be infected with a high intensity S. haematobium infection. Individuals from a low
SES status compared to individuals from a high SES status were 2 times more likely being
infected with S. mansoni (95% CI = 1.3–3.2; P = 0.00). There were not statistically significant
differences in the odds of being more heavily infected with S. mansoni between individuals
from medium and high SES status (OR: 1.3; 95% CI: 0.9–2; P = 0.18). High intensity S. man-
soni infections were less likely to be found in households with electricity (OR: 0.6; 95%
CI = 0.4–1; P = 0.04) if compared to households with no electricity.
Discussion
SCH and STH Prevalence
In the current study, the prevalence of schistosomiasis greatly exceeded that of STH across all
three study sites, this may be due to the main economic activities in this study community
being fishing as opposed to agriculture. Among the cases of schistosomiasis both urinary and
intestinal schistosomiasis were observed. S. mansoni was the most prevalent across all three
communities. The highest prevalence of S. mansoni was observed in Tomefa and the lowest
was seen in Manheam. For S. haematobium infections, Torgahkope-Adakope had the highest
prevalence with Manheam having the lowest. This difference of distribution across the sam-
pling sites may reflect the local economic activities across the different sites, similarly the dis-
tribution of the species may reflect differences in snail habitat favouring the host of one
Schistosoma species over another in different locations. Our study also shows that the preva-
lence of STH is negligible and far below the 20% recommended by WHO to justify annual
MDA [16]. This low prevalence means that STH is likely to be of little health importance in the
communities examined; further, there were insufficient positive samples for any statistical
models to be fitted on STH outcomes in our study.
Table 6. Odds Ratios (ORs) from two separate multivariable GEE proportional-odds cumulative logit models for
the outcomes of WHO categorical intensities of S. mansoni (n = 647) and S. haematobium (n = 1586) infections in
relation to morbidity indicators.
Comparisons between categories of covariates OR, (95% CI), p-value
S. mansoni Blood in Stool: Currently vs Not in last month 1.7 (1–2.9),0.076
Blood in Stool: In last month vs Not in last month 1.6 (1–2.6),0.050
Blood in Stool: Don’t Know vs Not in last month 0.6 (0.4–1.1),0.101
Diarrhoea: Currently vs Not in last month 1.4 (0.8–2.4),0.240
Diarrhoea: In last month vs Not in last month 1.6 (1–2.6),0.054
Diarrhoea: Don’t Know vs Not in last month 0.4 (0.2–0.8),0.010
Sex: Males vs Females 2.3 (1.7–3.3),<0.001
Age Category: Pre-School vs Adult 0.5 (0.1–2.2),0.328
Age Category: School vs Adult 0.1 (0.0–1.1),0.056
SES: Low vs High 2.0 (1.3–3.2),0.003
SES: Medium vs High 1.3 (0.9–2),0.176
Household electricity: Yes vs No 0.6 (0.4–1),0.035
Comparisons between categories of covariates OR, (95% CI), p-value
S. haematobium Blood in Urine: Currently vs Not in last month 2.7 (1.6–4.6),<0.001
Blood in Urine: In last month vs Not in last month 2.2 (1.4–3.3),0.001
Blood in Urine: Don’t Know vs Not in last month 0.5 (0.3–0.8),0.003
Sex: Males vs Females 1.5 (1.1–2.0),0.019
Age Category: Pre-School vs Adult 0.7 (0.4–1.3),0.251
Age Category: School vs Adult 2.3 (1.7–3.3),<0.001
https://doi.org/10.1371/journal.pntd.0007973.t006
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The prevalence and intensity of the disease between SAC and adults with regards to S. man-
soni (Tables 5 and 6) shows no significant difference overall and at individual site level. This
similarity in prevalence highlights the importance of treating the wider community, as adults
in all three study villages must be contributing significantly to the local transmission of the dis-
ease. However, for PSAC with S. mansoni there are significantly more infants from Tomefa
with an infection than from either Manheam or Torgahkope-Adakope, who both have similar
levels of PSAC infections to each other (Table 3). This suggests that treatment strategies with
regards to PSAC may need to change depending on the prevalence in communities, with
PSAC at higher risk in hyperendemic areas, such as Tomefa. The same was not found to be
true for S. haematobium where the prevalence was highest amongst SAC, followed by adults
and then PSAC (Table 3), although it should be noted that the prevalence of S. haematobium
was far lower than that of S. mansoni.
It should be noted that in calculating the prevalence and intensities, individuals that had
received praziquantel in the last 12 months were included. These individuals constituted only
0.89% of recruited community members and will take into consideration this portion of our
sample when we have collected follow-up data. However, we also anticipate that such low
numbers will have little effect on the overall prevalence and intensities observed.
Treatment coverage
The need to expand the treatment coverage is also important in the longer term as it increases
the likelihood that elimination of these two diseases as a public health problem can be achieved
in an environment where the sanitation and hygiene situation of the infected communities
may not improve. Mathematical modelling studies indicate that a relatively high coverage, of
85%, amongst SAC and 40%, amongst adults, is required to bring about the 2020 goals for
SCH morbidity control [23], in areas with moderate to high SCH. Despite having a high pres-
ence in the community our study fell slightly short of the coverage required for the SAC with a
coverage of ~80%. The coverage of the adult population was more promising as we were able
to exceed the 40%, calculated, for SCH control [23]. The largest proportion of those that did
not receive treatment did so due to being absent. A possible way to increase the coverage
would be to treat the participants during the survey and sample collection phase. Alternatively,
leaving the drugs behind and having a community member trained in their dispensation
would allow those who were absent to seek treatment if missed by the MDA. Following on
from those that were absent refusal to receive treatment was the second biggest reason for peo-
ple to not receive treatment. Reasons for refusal are unknown as our study did not include
questions for justification of refusal. Only a small percentage were not treated due to meeting
the exclusion. The number of individuals who had received treatment in the last 12 months
was minimal, 0.8% (95% CI = 0.5–1.3). The results of the baseline survey reveal that the pres-
ence of STH was negligible with a combined prevalence of 1.59%, far below the 20% recom-
mended by WHO to justify annual MDA [16].
WASH, household, SES and morbidity indicators of schistosomiasis
Self-reported morbidity indicators were found to be significantly associated with high intensity
infections (Table 6). Morbidity indicators such as blood in stool or urine and diarrhoea (also
observed in our study) have been previously identified as indicators of moderate and heavy
intensities of S. mansoni or S. haematobium infections [49, 59]. Being of lower socio-economic
status was suggested to be a risk factor for high intensity S. mansoni infection whereas the
treatment of water and the availability of household electricity were associated with a reduced
intensity of infection and a lower probability of S. mansoni infection (Tables 5 and 6). Both
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urinating in the school toilet and defecating in the village toilet were identified as being related
to lower risk of having an S. haematobium infection. Oddly household electricity was associ-
ated with an increase likelihood of being positive for S. haematobium (Table 5). The latter find-
ing is surprising and merits further investigation to enable us to give a more reasonable
explanation in the near future, but it is unlikely that having household electricity directly con-
tributes to an increased risk of S. haematobium infection, but rather there is a secondary
relationship.
Urinating and defecating in school and village toilets was associated with lower risk of
schistosomiasis infection. Conversely, the use of neighbour’s toilet was linked to an increased
risk of schistosomiasis infection. These patterns of toilet use are likely not directly contributing
to the transmission of disease, unless these shared latrines are acting as a focal point of contam-
ination, but instead may indicate areas with a general lack of appropriate waste disposal and
sanitation infrastructure. This relates back to an increased risk of schistosomiasis as a lack of
toilets could lead to behaviours such as open defecation or urination in or near waterbodies,
resulting in local transmission of the disease.
Considering the high prevalence of both schistosome species, but especially S. mansoni it is
surprising that no significant link was identified between schistosomiasis infection and either
the nearby water reservoir, faecal/urine disposal habits or bathing habits. There was no strong
link between any of the defecation or urination habits recorded by the questionnaire and an
increased risk of schistosomiasis, similarly the occupation of those involved, notably fishing,
was not associated with risk of infection or intensity of infection. This may be due to the
answers given, the most common location for defecation, besides toilets, were the ground and
the bush. These answers in no way indicate proximity to the shore of the reservoir. In total
only 13 out of 2,429 individuals reported they defecated in the reservoir or a river. This dis-
crepancy highlights the difficulty in extracting behavioural patterns from communities that
sustain transmission. With the prevalence of S. mansoni as high as 78% across the entire com-
munity there must be local contamination of the immediate area with faeces. However, no
behaviours associated with defecation were identified as significant risk factors for schistoso-
miasis infection.
Mapping and SCH control
Our study raises questions over the suitability of mapping and surveillance methods in the
context of the WHO goals for schistosomiasis control and elimination. With such a highly
focal disease as schistosomiasis the ability to direct the MDA campaigns to the correct commu-
nities is crucial. This is evident in Table 2 with the different prevalences of both S. mansoni
and S. haematobium differing significantly between sites. These differences in prevalence may
require different intervention strategies, however at a greater scale this resolution is lost. How-
ever, being able to empirically assess each community for SCH prevalence is not possible and
studies have shown that models attempting to project out the prevalence of the disease from
available data are often inaccurate and operate on the wrong scale, typically at the district level
[60]. The importance of precision mapping strategies are required has been identified [61].
Study limitations
The authors accept that there are a number of limitations to their study, of importance is the
use of self-reported morbidity indicators. By not having an objective morbidity assessment it is
not possible to associate health problems reported by community members with schistosomia-
sis whilst controlling for confounders. However, the choice for self-reporting can be defended
as it was pragmatic choice that has been used in other studies. Naturally with more resources it
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would have been possible to assess morbidity from a more objective and clinical persepective,
however our study lacked the resources and time was a limiting factor, as the authors hoped to
strike a balance between accuracy and reducing the time our study impacted the communities’
time.
Similarly, the socio-economic assessment could have been more detailed, which would
have helped in better stratifying the communities. Only three questions were used to stratify
the SES scale, inclusion of more wealth indicator may have created a higher resolution SES.
Another limitation of this study is the failure to capture reasons for treatment-refusal.
Whilst the study was able to identify broad reasons for individuals not receiving treatment,
(such as met exclusion criteria, was away, refused etc), the questionnaire did not capture spe-
cific reasons for refusal. Such information would have been useful in understanding how to
include this group in future MDA interventions. A final limitation of the study is the potential
that some communities may have been oversampled whilst others may have been under sam-
pled, as the sample size was calculated for a community of 1,500 people in size, yet the esti-
mated size of Torgahkope-Adakope was ~911 and that of Manheam was ~3,954. However,
there is no way to know the true populations of these communities, with the estimates for pop-
ulation size being derived from the total number of enumerated houses multiplied by average
household number per community.
Conclusion
The three communities sampled differed in the prevalence of S. mansoni with Manheam and
Torgahkope-Adakope having significantly lower prevalences than Tomefa. The prevalence of
S. haematobium was significantly lower than that of S. mansoni in all three communities,
although like S. mansoni the prevalence also differed by site, with Manheam having signifi-
cantly fewer cases than either Torgahkope-Adakope or Tomefa. The prevalence of STH species
was found to be very low in these communities, possibly due to fishing being the primary eco-
nomic activity as opposed to agriculture. Individuals of a lower socioeconomic background
were more likely to be infected with both species of Schistosoma and the prevalence of the dis-
ease was similar in both the adult and SAC populations supporting the argument that current
methods of treating just the SAC members of a community are insufficient if regional elimina-
tion of SCH is to be achieved. This study also supports previous findings with regard to self-
reported morbidity indicators being positively correlated with both S. mansoni and S. haema-
tobium infections. The prevalence of schistosomiasis was also considerably high in PSAC, even
to the point of no significant difference between the age groups and prevalence of S. mansoni
at the Tomefa site. The issue of achieving high coverage of drug adherence is critical as it has
been calculated that high coverage rates are required if the 2020 goals are to be achieved. These
coverage rates were not easy to achieve amongst the SAC although the coverage rate required
for adults was exceeded. Currently the major hurdles to overcome in order to expand PZQ to
the whole community include data demonstrating sufficient burden to warrant treatments,
scale up of the donation or acquisition of PZQ for those cohorts currently not being treated
and the development of a robust method for drug distribution. A flexible enough method of
drug distribution to accommodate for absenteeism, which is one of the leading causes for non-
compliance, is also required. The donation and availability of a formulation of PZQ for pre-
school age children is also critical, especially for the treatment of PSAC in communities with a
high prevalence of disease. It is primarily these reasons that community wide MDA of PZQ is
rarely implemented despite it being recommended and widely accepted by the academic com-
munity in areas of high prevalence.
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Finally, the use of complimentary interventions, such as snail-control, introduction of
WASH practices and improvements to infrastructure, should also be employed alongside com-
munity wide MDA, whenever possible.
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